Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

144 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Safety Study in Patients With Chronic Lymphocytic Leukemia

NCT00283101

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Weill Medical College/Cornell University New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

NCT00079716

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • James R. Berenson M.D., Inc. West Hollywood, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cornell University New York, United States
View Trial Details
Completed

A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma

NCT00103779

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stanford University Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Cornell University New York, United States
View Trial Details
Completed

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

NCT00525447

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

NCT01273090

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details

Related conditions